ACGQX
Price
$21.81
Change
-$0.24 (-1.09%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

ACGQX vs RMFCX

Header iconACGQX vs RMFCX Comparison
Open Charts ACGQX vs RMFCXBanner chart's image
Invesco Growth and Income R5
Price$21.81
Change-$0.24 (-1.09%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
ACGQX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ACGQX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACGQX is a Sell and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. ACGQX (4.23B). RMFCX (1.69) and ACGQX (1.61) have matching dividends . ACGQX was incepted earlier than RMFCX: ACGQX (15 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. ACGQX (21.00). RMFCX has a lower initial minimum investment than ACGQX: RMFCX (250) vs ACGQX (1000000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. ACGQX (10.14). RMFCX return over 5 years is better than : 40.39 vs. ACGQX (-0.39).
ACGQXRMFCXACGQX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years23 years-
Gain YTD8.94511.42378%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.23B104B4%
Annual Yield % from dividends1.611.6995%
Returns for 1 year10.1412.6380%
Returns for 3 years-2.7914.16-20%
Returns for 5 years-0.3940.39-1%
Returns for 10 years-6.6361.84-11%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc